down arrow

Concord Biotech

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE338H01029
  • NSEID: CONCORDBIO
  • BSEID: 543960
INR
1,660.00
59.35 (3.71%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 68.17 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Mar'23
Mar'22
Net Sales
1,016.94
853.17
712.93
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,016.94
853.17
712.93
Raw Material Cost
184.54
167.07
157.26
Purchase of Finished goods
56.74
28.77
30.73
(Increase) / Decrease In Stocks
-12.08
-15.63
-23.98
Employee Cost
123.05
110.28
95.69
Power Cost
104.97
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
128.16
219.39
179.96
Total Expenditure (Excl Depreciation)
585.38
509.88
439.66
Operating Profit (PBDIT) excl Other Income
431.56
343.29
273.27
Other Income
33.78
35.31
23.42
Operating Profit (PBDIT)
465.34
378.60
296.69
Interest
2.55
4.51
5.48
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
462.79
374.09
291.21
Depreciation
53.59
54.03
50.05
Profit Before Tax
409.20
320.05
241.16
Tax
104.46
81.93
62.59
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
304.73
238.13
178.57
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
304.73
238.13
178.57
Share in Profit of Associates
3.37
1.96
-3.64
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
308.10
240.09
174.93
Equity Capital
10.46
10.46
9.51
Face Value
1.0
1.0
10.0
Reserves
1,516.18
1,279.54
1,093.71
Earnings per share (EPS)
29.46
22.95
16.72
Diluted Earnings per share
29.45
22.95
183.34
Operating Profit Margin (Excl OI)
42.44%
40.24%
38.33%
Gross Profit Margin
45.51%
43.85%
40.85%
PAT Margin
30.3%
28.14%
24.54%
Public Share Holdings (%)
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 19.20% vs 19.67% in Mar 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2024 is 28.33% vs 37.25% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is 25.71% vs 25.62% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is -43.46% vs -17.70% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2024 has improved from Mar 2023

Compare Annual Results Of Concord Biotech With
Markets Mojo
Figures in Rs cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,016.94
10,334.77
-9,317.83
-90.16%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,016.94
10,334.77
-9,317.83
-90.16%
Raw Material Cost
184.54
1,853.52
-1,668.98
-90.04%
Purchase of Finished goods
56.74
1,409.85
-1,353.11
-95.98%
(Increase) / Decrease In Stocks
-12.08
-53.67
41.59
77.49%
Employee Cost
123.05
2,274.73
-2,151.68
-94.59%
Power Cost
104.97
0.00
104.97
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
128.16
2,315.28
-2,187.12
-94.46%
Total Expenditure (Excl Depreciation)
585.38
7,799.71
-7,214.33
-92.49%
Operating Profit (PBDIT) excl Other Income
431.56
2,535.06
-2,103.50
-82.98%
Other Income
33.78
280.86
-247.08
-87.97%
Operating Profit (PBDIT)
465.34
2,815.92
-2,350.58
-83.47%
Interest
2.55
33.53
-30.98
-92.39%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
462.79
2,782.39
-2,319.60
-83.37%
Depreciation
53.59
398.25
-344.66
-86.54%
Profit Before Tax
409.20
2,384.14
-1,974.94
-82.84%
Tax
104.46
457.58
-353.12
-77.17%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
304.73
1,926.56
-1,621.83
-84.18%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
304.73
1,926.56
-1,621.83
-84.18%
Share in Profit of Associates
3.37
15.21
-11.84
-77.84%
Minority Interest
0.00
-28.87
28.87
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
308.10
1,912.90
-1,604.80
-83.89%
Equity Capital
10.46
40.06
-29.60
-73.89%
Face Value
1.00
1.00
0.00
Reserves
1,516.18
9,323.03
-7,806.85
-83.74%
Earnings per share (EPS)
29.46
47.75
-18.29
-38.30%
Diluted Earnings per share
29.45
47.68
-18.23
-38.23%
Operating Profit Margin (Excl OI)
42.44%
24.53%
0.00
17.91%
Gross Profit Margin
45.51%
26.92%
0.00
18.59%
PAT Margin
30.30%
18.79%
0.00
11.51%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 1,016.94 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 19.20% vs 19.67% in Mar 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 308.10 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 28.33% vs 37.25% in Mar 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 431.56 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 25.71% vs 25.62% in Mar 2023

Annual - Interest
Interest 2.55 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -43.46% vs -17.70% in Mar 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 42.44%
in Mar 2024

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2024 has improved from Mar 2023